Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The mutation frequency of feline immunodeficiency virus enhanced by 3'-azido-3'-deoxythymidine

Article Abstract:

The drug AZT may increase the mutation rate of HIV. AZT is the most commonly used drug in the treatment of HIV infection and AIDS. Researchers used a culture of kidney cells from cats to measure the effect of AZT and two other AIDS drugs on the mutation rate of feline immunodeficiency virus (FIV). FIV is related to HIV and causes an immune deficiency in cats. The feline kidney cell culture was exposed to a known mutagen, 5-bromo-2'-deoxyuridine (BUdR), to determine a baseline range of mutated viruses. Then similar cultures were exposed to AZT, ddI or ddC. AZT increased the mutation rate of FIV in a manner similar to BUdR. ddI and ddC did not cause a detectable increase in the mutation rate of FIV.

Author: LaCasse, Rachel A., Remington, Kathryn M., North, Thomas W.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1996
Zidovudine, Feline immunodeficiency virus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Epstein-Barr virus DNA in the blood of infants, young children, and adults by age and HIV status

Article Abstract:

High levels of Epstein-Barr virus (EBV) DNA in the blood of children infected with HIV may be associated with lower concentrations of HIV in the blood. Researchers studied mononuclear white blood cells in children infected with HIV before birth and their HIV-infected mothers. Children infected with both viruses typically had EBV DNA levels hundreds of times higher than the women who were coinfected. EBV may have proliferated in the children after maternally acquired immunity declined. High levels of EBV DNA in children were associated with lower HIV viral load.

Author: Rakusan, Tamara A., Brandt, Carl D., Sison, Antonio V., Kaufman, Thomas E., Saxena, Ela S., O'Donnell, Regina M., Sever, John L.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1998
Physiological aspects, HIV infection in children, Pediatric HIV infections, Viruses, Epstein-Barr virus diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The Kin-cohort study for estimating penetrance

Article Abstract:

A cross-sectional study is probably more suitable than a cohort or case-control study for studying the effect of a rare mutation in a cancer gene. The kin-cohort method uses volunteer infected subjects who have a higher risk of mutation. Researchers can infer the penetration of the mutation by averaging the risk in carriers and non-carriers and weight calculation.

Author: Wacholder, Sholom, Hartge, Patricia, Brody, Lawrence, Struewing, Jeffrey P., McAdams, Mary, Pee, David, Tucker, Margaret
Publisher: Johns Hopkins University Press
Publication Name: American Journal of Epidemiology
Subject: Health
ISSN: 0002-9262
Year: 1998
Evaluation, Cohort analysis, Genetic research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Mutation (Biology), Mutation
Similar abstracts:
  • Abstracts: The distribution and mortality impact of chronic energy deficiency among adult Nigerian men and women. Energy requirements: general principles
  • Abstracts: Let's put an end to pain. Hounded by pain
  • Abstracts: Fetal surgery. Morbidity and mortality of incontinence surgery in elderly women: an analysis of Medicare data
  • Abstracts: Diffusion of innovative approaches to managing hypoplastic left heart syndrome. Fetal alcohol syndrome at the turn of the 20th century: an unexpected explanation of the Kallikak family
  • Abstracts: Critical of care: nurses are not equal in status to doctors, with whom they may find themselves in conflict when acting as patients' advocate. part 2
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.